The remainder of 2021 is expected to continue reeling under the spurt in coronavirus cases. Thus, a COVID-themed ETF could be a wise choice.
The Biden administration recently offered a $65 billion plan that U.S. officials say is aimed at combating the biological threats after the COVID-19 pandemic goes away.
We have highlighted five ETFs from different sectors that hit new peaks in the recent trading session and have been the leaders in their respective sector so far this year.
Sanofi has agreed to acquire U.S. biotech company Translate Bio to gain exposure in the mRNA vaccine space.
Netflix (NFLX) once again disappointed investors with lesser subscriber growth.
After disappointing first-quarter earnings results, with lesser subscriber growth, investors are keen to watch whether Netflix managed to win subscribers in the second quarter amid stiff competition.
Novavax (NVAX) is reportedly set to receive the fourth authorization for COVID-19 vaccine in the United States.
Thermo Fisher Scientific (TMO) has agreed to buy the healthcare testing company PPD Inc. (PPD) for $17.4 billion in cash.
The first half of 2021 is expected to continue bearing the brunt of the coronavirus outbreak considering the pandemic's renewed resurgence thanks to variants. Thus, a COVID-themed ETF could be a smart...
On Mar 1 after the bell, Zoom Video Communications (ZM) crushed estimates for its fiscal fourth-quarter earnings.